跳至主要内容
临床试验/NCT02131220
NCT02131220已完成4 期

A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON

Fudan University1 个研究点 分布在 1 个国家目标入组 362 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
362
试验地点
1
主要终点
Coronary flow using corrected Thrombolysis In Myocardial Infarction Frame Count (cTFC)

研究概览

简要总结

The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ST-segment elevation AMI within 12 hours of symptom onset

排除标准

  • Contraindications to thrombolysis or PCI
  • Patients administered a fibrinolytic agent before PCI
  • Patients enrolled in clinical trials

研究组 & 干预措施

Prourokinase

Experimental

Intracoronary bolus infusion of 20mg prourokinase using selective catheter

干预措施: Prourokinase (Drug)

Tirofiban

Active Comparator

Intracoronary tirofiban bolus infusion using selective catheter (10ug/kg)

干预措施: Tirofiban (Drug)

Normal saline

Placebo Comparator

Intracoronary saline bolus infusion using selective catheter (20ml)

干预措施: normal saline (Drug)

结局指标

主要结局

Coronary flow using corrected Thrombolysis In Myocardial Infarction Frame Count (cTFC)

时间窗: At the end of Percutaneous Coronary Intervention procedure

次要结局

  • incidence of major adverse cardiac events (MACE) defined as the composite of death, myocardial infarction and target vessel revascularization(30 days post PCI)
  • infarction area confirmed by SPECT(30 days post PCI)
  • ST segment resolution in ECG(3 hours post PCI procedure)
  • peak troponin T level(in the 7 days post PCI procedure)
  • plasma N terminal-proBNP levels(1 and 30 days post PCI procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ge Junbo

Director, Dept. of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital

Fudan University

研究点 (1)

Loading locations...

相似试验